ANEB - Anebulo Pharmaceuticals reports FQ3 results June, 21 2021 04:08 PM Anebulo Pharmaceuticals Inc. Anebulo Pharmaceuticals (ANEB): FQ3 GAAP EPS of -$0.69.Cash and cash equivalents were $3.3M as of March 31, 2021.Press Release For further details see: Anebulo Pharmaceuticals reports FQ3 results